These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Gamma probe-guided resection and scanning with TC-99m MIBI of a local recurrence of follicular thyroid carcinoma. Boz A; Arici C; Güngör F; Yildiz A; Colak T; Karayalçin B Clin Nucl Med; 2001 Oct; 26(10):820-2. PubMed ID: 11564916 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi. Sundram FX; Mack P Nucl Med Commun; 1995 Aug; 16(8):687-93. PubMed ID: 7491182 [TBL] [Abstract][Full Text] [Related]
34. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan. Kaya M; Cermik TF Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510 [TBL] [Abstract][Full Text] [Related]
35. Discordant uptake of Tl-201 and Tc-99m MIBI in a patient with follicular adenoma. Erdil TY; Turoğlu HT Ann Nucl Med; 2000 Apr; 14(2):135-8. PubMed ID: 10830533 [TBL] [Abstract][Full Text] [Related]
36. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results. Küçük NO; Külak HA; Aras G Ann Nucl Med; 2006 Jul; 20(6):393-7. PubMed ID: 16922467 [TBL] [Abstract][Full Text] [Related]
37. [High retention of (99m)Tc-MIBI in delayed phase as a pitfall in the combined parathyroid-thyroid scintigraphy]. Verdú J; Lizárraga C; Clavel J; Prata I; Calbo J; Pomares F Rev Esp Med Nucl; 2010; 29(5):251-3. PubMed ID: 20381207 [TBL] [Abstract][Full Text] [Related]
38. Investigation of thyroid nodules using technetium-99m sestamibi. Sundram FX; Mack PO Ann Acad Med Singap; 1993 Jul; 22(4):560-2. PubMed ID: 8257058 [No Abstract] [Full Text] [Related]